Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

Overactive bladder (OAB) is defined as urinary urgency, with or without urge incontinence, often with frequency and nocturia. Initial therapy of OAB often includes anticholinergics and behavioral ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...

Magnetic stimulation plus bladder training and TTNS plus bladder training are both more effective than bladder training alone. (HealthDay News) — For women with idiopathic overactive bladder (iOAB), ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Urinary and bowel disorders, manifesting as symptoms like frequent urination or difficulty in bowel movements, can greatly impact one’s quality of life, even though they are not outwardly visible.

Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...

Overactive bladder (OAB) is prevalent among women with fibromyalgia (FM) and is associated with higher symptom severity and comorbidity, according to a study published in Neurourology Urodynamics.